Cervical Cancer

• USPSTF Recommendation:
  • Ages 30-65: Screen every 3 years with cervical cytology alone, every 5 years with high-risk human papillomavirus (hrHPV) testing alone, or every 5 years with hrHPV testing in combination with cytology (cotesting).  
  • Ages 21-29: Screen every 3 years with cervical cytology alone.
  • Ages 65 and older: If adequate prior screening and no history of cervical intraepithelial neoplasia (CIN) 2 or higher, or cervical cancer, screening may be discontinued.

2. Breast Cancer

• USPSTF Recommendation:
  • Ages 40-49: The USPSTF recommends against routine screening for women aged 40 to 49 years.
  • Ages 50-74: The USPSTF recommends biennial screening mammography.
  • Ages 75 years or older: The USPSTF concludes that the evidence is insufficient to assess the balance of benefits and harms of screening mammography.

3. Osteoporosis

• USPSTF Recommendation:
  • Women aged 65 years and older: The USPSTF recommends screening for osteoporosis.
  • Postmenopausal women younger than 65 years who are at increased risk of osteoporosis: The USPSTF recommends screening for osteoporosis.

4. Colorectal Cancer

• USPSTF Recommendation:
  • Ages 50-75: The USPSTF recommends screening for colorectal cancer.
  • Ages 76-85: The USPSTF concludes that the evidence is insufficient to assess the balance of benefits and harms of screening.

5. Lung Cancer

• USPSTF Recommendation:
  • Adults aged 50 to 80 years who have a 20-pack-year smoking history and currently smoke or have quit within the past 15 years: The USPSTF recommends annual screening with low-dose computed tomography (LDCT).  

6. Ovarian Cancer

• USPSTF Recommendation:
  • The USPSTF concludes that the evidence is insufficient to assess the balance of benefits and harms of screening for ovarian cancer in asymptomatic women.

7. Intimate Partner Violence (IPV)

• USPSTF Recommendation:
  • The USPSTF recommends that clinicians screen all women of reproductive age for IPV during routine well-woman visits.

Note:

• These are general recommendations and may need to be adjusted based on individual patient factors and risk assessments.
• It’s crucial for healthcare providers to stay updated on the latest USPSTF guidelines and discuss screening options with their patients to make informed decisions based on individual needs and preferences.

Disclaimer: This information is for general knowledge and informational purposes only and does not constitute medical advice.